Investing.com - T-Mobile US added more wireless subscribers than anticipated in the fourth quarter and provided an upbeat outlook for 2025, in a sign of enduring strength in demand for its discounted plans offering bundled streaming services such as Netflix (NASDAQ:NFLX).
Shares in T-Mobile US (NASDAQ:TMUS) surged by more than 8% in premarket U.S. trading on Wednesday.
The telecom group's high-speed 5G plans are often more affordable than those from rivals like AT&T (NYSE:T) and Verizon (NYSE:VZ), while its premium products such as Go5G Next (LON:NXT) and Go5G Plus includes perks like streaming video.
Postpaid phone net customers increased by 903,000 during the quarter ended on December 31, topping Bloomberg consensus estimates of 864,539.
In a statement, CEO Mike Sievert said the firm was also issuing the "strongest start-of-year" guidance for bill-paying net customer additions in its history.
Postpaid net subscribers are seen rising by 5.50 million to 6 million, surpassing analysts' expectations of 5.23 million, according to Bloomberg consensus estimates. In 2024, the figure came in at 6.1 million, above T-Mobile US's previously-improved guidance range.
Quarterly revenue jumped by 6.8% versus the year-ago period to $21.87 billion, compared with projections of $21.35 billion. Earnings per share for the period was $2.57.
Meanwhile, adjusted free cash flow, a key metric used to help determine dividend payouts, was $4.1 billion in the quarter and $17 billion in 2024. For the current year, the gauge is seen at $17.30 billion to $18 billion, above Bloomberg forecasts at the midpoint.
T-Mobile previously projected that the number would be between $18 billion to $19 billion in 2027.
In December, T-Mobile US said it would repurchase as much as $14 billion in shares by the end of 2025 as part of a three-year push to return up to $50 billion to stakeholders. The company, along with AT&T and Verizon, are some of the biggest dividend payers in the U.S.
Related Articles
T-Mobile wireless subscriber additions top estimates, sending shares higher
Goldman Sachs upgrades Carl Zeiss Meditec to 'neutral' after sharp decline
ASML order boom reassures investors after DeepSeek sell off
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.